The University of Chicago Header Logo

Connection

Sangeeta Bhorade to Primary Graft Dysfunction

This is a "connection" page, showing publications Sangeeta Bhorade has written about Primary Graft Dysfunction.
Connection Strength

1.957
  1. Quantitative Evidence for Revising the Definition of Primary Graft Dysfunction after Lung Transplant. Am J Respir Crit Care Med. 2018 01 15; 197(2):235-243.
    View in: PubMed
    Score: 0.158
  2. Clinical Risk Factors and Prognostic Model for Primary Graft Dysfunction after Lung Transplantation in Patients with Pulmonary Hypertension. Ann Am Thorac Soc. 2017 Oct; 14(10):1514-1522.
    View in: PubMed
    Score: 0.155
  3. The relationship between plasma lipid peroxidation products and primary graft dysfunction after lung transplantation is modified by donor smoking and reperfusion hyperoxia. J Heart Lung Transplant. 2016 Apr; 35(4):500-507.
    View in: PubMed
    Score: 0.137
  4. Protein Quantitative Trait Loci Analysis Identifies Genetic Variation in the Innate Immune Regulator TOLLIP in Post-Lung Transplant Primary Graft Dysfunction Risk. Am J Transplant. 2016 Mar; 16(3):833-40.
    View in: PubMed
    Score: 0.136
  5. Objective Estimates Improve Risk Stratification for Primary Graft Dysfunction after Lung Transplantation. Am J Transplant. 2015 Aug; 15(8):2188-96.
    View in: PubMed
    Score: 0.130
  6. Plasma complement levels are associated with primary graft dysfunction and mortality after lung transplantation. Am J Respir Crit Care Med. 2014 Jun 15; 189(12):1564-7.
    View in: PubMed
    Score: 0.123
  7. Genetic variation in the prostaglandin E2 pathway is associated with primary graft dysfunction. Am J Respir Crit Care Med. 2014 Mar 01; 189(5):567-75.
    View in: PubMed
    Score: 0.121
  8. Preoperative plasma club (clara) cell secretory protein levels are associated with primary graft dysfunction after lung transplantation. Am J Transplant. 2014 Feb; 14(2):446-52.
    View in: PubMed
    Score: 0.119
  9. Latent class analysis identifies distinct phenotypes of primary graft dysfunction after lung transplantation. Chest. 2013 Aug; 144(2):616-622.
    View in: PubMed
    Score: 0.116
  10. Clinical risk factors for primary graft dysfunction after lung transplantation. Am J Respir Crit Care Med. 2013 Mar 01; 187(5):527-34.
    View in: PubMed
    Score: 0.111
  11. Elevated plasma angiopoietin-2 levels and primary graft dysfunction after lung transplantation. PLoS One. 2012; 7(12):e51932.
    View in: PubMed
    Score: 0.111
  12. Variation in PTX3 is associated with primary graft dysfunction after lung transplantation. Am J Respir Crit Care Med. 2012 Sep 15; 186(6):546-52.
    View in: PubMed
    Score: 0.108
  13. A panel of lung injury biomarkers enhances the definition of primary graft dysfunction (PGD) after lung transplantation. J Heart Lung Transplant. 2012 Sep; 31(9):942-9.
    View in: PubMed
    Score: 0.107
  14. Obesity and primary graft dysfunction after lung transplantation: the Lung Transplant Outcomes Group Obesity Study. Am J Respir Crit Care Med. 2011 Nov 01; 184(9):1055-61.
    View in: PubMed
    Score: 0.103
  15. Elevated plasma long pentraxin-3 levels and primary graft dysfunction after lung transplantation for idiopathic pulmonary fibrosis. Am J Transplant. 2011 Nov; 11(11):2517-22.
    View in: PubMed
    Score: 0.101
  16. Elevated plasma clara cell secretory protein concentration is associated with high-grade primary graft dysfunction. Am J Transplant. 2011 Mar; 11(3):561-7.
    View in: PubMed
    Score: 0.097
  17. Effect of single vs bilateral lung transplantation on plasma surfactant protein D levels in idiopathic pulmonary fibrosis. Chest. 2011 Aug; 140(2):489-496.
    View in: PubMed
    Score: 0.024
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.